The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14583450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.

  2003cited by this paper
• p53 regulation of DNA excision repair pathways.

  2002cited by this paper
• p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.

  2001cited by this paper
• Mammalian p53R2 Protein Forms an Active Ribonucleotide Reductasein Vitro with the R1 Protein, Which Is Expressed Both in Resting Cells in Response to DNA Damage and in Proliferating Cells*

  2001cited by this paper
• A ribonucleotide reductase gene is a transcriptional target of p53 and p73

  2000influential reference
• A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

  2000influential reference
• Cancer: p53 sends nucleotides to repair DNA

  2000cited by this paper
• Inhibition of Human Cancer Cell Growth by Inducible Expression of Human Ribonucleotide Reductase Antisense cDNA

  2000cited by this paper
• Functions of the MDM2 oncoprotein

  1999cited by this paper
• Regulation of p53 in response to DNA damage

  1999cited by this paper
• Adaptive enhancement and kinetics of nucleotide excision repair in humans.

  1999cited by this paper
• Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair.

  1999cited by this paper
• Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair.

  1999cited by this paper
• Ribonucleotide reductases.

  1998cited by this paper
• Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation.

  1998cited by this paper
• p48 Activates a UV-Damaged-DNA Binding Factor and Is Defective in Xeroderma Pigmentosum Group E Cells That Lack Binding Activity

  1998cited by this paper
• Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells.

  1998cited by this paper
• Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

  1998cited by this paper
• A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK.

  1998cited by this paper
• A model for p53-induced apoptosis

  1997cited by this paper
• Expression of Wild-type p53 Is Required for Efficient Global Genomic Nucleotide Excision Repair in UV-irradiated Human Fibroblasts*

  1997cited by this paper
• p53 Mediates Permanent Arrest over Multiple Cell Cycles in Response to γ-Irradiation

  1997cited by this paper
• Recruitment of p300/CBP in p53-dependent signal pathways.

  1997cited by this paper
• p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation.

  1997cited by this paper
• p53 and ATM: cell cycle, cell death, and cancer.

  1997cited by this paper
• p53-mediated protective responses to UV irradiation.

  1997cited by this paper
• Binding and modulation of p53 by p300/CBP coactivators

  1997cited by this paper
• Synergistic activation of transcription by CBP and p53

  1997cited by this paper
• Functional interactions between p53 and the TFIIH complex are affected by tumour‐associated mutations.

  1996cited by this paper
• Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.

  1995cited by this paper
• Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1.

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• p53 modulation of TFIIH–associated nucleotide excision repair activity

  1995cited by this paper
• Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.

  1995cited by this paper
• Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer.

  1994cited by this paper
• DNA repair rates mapped along the human PGK1 gene at nucleotide resolution.

  1994cited by this paper
• Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine.

  1994cited by this paper
• Replitase: a complex integrating dNTP synthesis and DNA replication.

  1993cited by this paper
• Structure and promoter characterization of the gene encoding the large subunit (R1 protein) of mouse ribonucleotide reductase.

  1993cited by this paper
• Replitase: a complex integrating dNTP synthesis and DNA replication.

  1993cited by this paper
• Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent.

  1992cited by this paper
• Escherichia coli ribonucleotide reductase expression is cell cycle regulated.

  1992cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.

  1990cited by this paper
• Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild‐type and mutant S49 T lymphoma cells

  1990cited by this paper
• DNA damage induction of ribonucleotide reductase

  1989cited by this paper
• Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase.

  1988cited by this paper
• Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation.

  1988cited by this paper
• Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase

  1986cited by this paper
• Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits.

  1985cited by this paper
• Subunit M2 of mammalian ribonucleotide reductase. Characterization of a homogeneous protein isolated from M2-overproducing mouse cells.

  1985cited by this paper
• Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis.

  1984cited by this paper
• Localization of ribonucleotide reductase in mammalian cells.

  1984cited by this paper
• Substrate specificity of human ribonucleotide reductase from Molt-4F cells.

  1979cited by this paper

• Case Report: A novel RRM2B variant in a Chinese infant with mitochondrial DNA depletion syndrome and collective analyses of RRM2B variants for disease etiology

  2024cites this paper
• Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer

  2022cites this paper
• A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients

  2021cites this paper
• Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma

  2020cites this paper
• Identi cation and Validation of Three Core Genes in p53 Signaling Pathway in Hepatitis B Virus-Related Hepatocellular Carcinoma

  2020cites this paper
• Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis

  2020cites this paper
• The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells

  2019cites this paper
• Rrm2b deletion causes mitochondrial metabolic defects in renal tubules

  2019cites this paper
• Conditional Knockdown of Osteopontin Inhibits Breast Cancer Skeletal Metastasis

  2019cites this paper
• A homozygous variant in RRM2B is associated with severe metabolic acidosis and early neonatal death.

  2019cites this paper
• Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.

  2018cites this paper
• Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication

  2017cites this paper
• Combination Radiation Therapy and Oncolytic Vaccinia Virus Therapy in Preclinical Models of Glioma

  2017cites this paper
• p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma

  2017cites this paper
• p53R2 regulates thioredoxin reductase activity through interaction with TrxR2.

  2017cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2017cites this paper
• MEK inhibition in pancreas cancer

  2016cites this paper
• RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease.

  2016cites this paper
• ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.

  2016cites this paper
• PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress

  2016cites this paper
• Ribonucleotide reductase large subunit M1 plays a different role in the invasion and metastasis of papillary thyroid carcinoma and undifferentiated thyroid carcinoma

  2016cites this paper
• RRM2B-Mediated Regulation of Mitochondrial Activity and Inflammation under Oxidative Stress

  2015cites this paper
• Novel mechanisms for superoxide-scavenging activity of human manganese superoxide dismutase determined by the K68 key acetylation site.

  2015cites this paper
• Clofarabine Has Apoptotic Effect on T47D Breast Cancer Cell Line via P53R2 Gene Expression.

  2015cites this paper
• Application of a cDNA microarray for profiling the gene expression of Echinococcus granulosus protoscoleces treated with albendazole and artemisinin.

  2014cites this paper
• Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients

  2014cites this paper
• Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase.

  2014cites this paper
• Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.

  2014cites this paper
• Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1‐mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma

  2014cites this paper
• Akt and p53R2, partners that dictate the progression and invasiveness of cancer.

  2014cites this paper
• Ribonucleotide Reductase Expression in Cervical Cancer: A Radiation Therapy Oncology Group Translational Science Analysis

  2013cites this paper
• Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein

  2013cites this paper
• Targeting ribonucleotide reductase for cancer therapy

  2013cites this paper
• THE P53-NMNAT2 FEEDBACK REGULATORY LOOP: MECHANISMS UNDERLYING P53 ACTIVATION

  2012cites this paper
• Assessment of the overall impact of diet on colorectal cancer in Cambodia, with special emphasis on endogenous and exogenous chemicals

  2012cites this paper
• Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis

  2012cites this paper
• Molecular insights into the proliferation and progression mechanisms of the oral cancer: Strategies for the effective and personalized therapy

  2012cites this paper
• Regulation of urokinase expression at the posttranscription level by lung epithelial cells.

  2012cites this paper
• 核糖核苷酸还原酶和非小细胞肺癌

  2012cites this paper
• Progesterone and DNA Damage Encourage Uterine Cell Proliferation and Decidualization through Up-regulating Ribonucleotide Reductase 2 Expression during Early Pregnancy in Mice*

  2012cites this paper
• Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer.

  2012cites this paper
• Molecular analysis and functions of p53R2 in zebrafish.

  2011cites this paper
• Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.

  2011cites this paper
• Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies.

  2011cites this paper
• Therapeutic Discovery p 53 R 2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest

  2011cites this paper
• 1 p 53 R 2 inhibits the proliferation of human cancer cells in association with cell cycle arrest

  2011cites this paper
• Identification and Characterization of Alternative Promoters, Transcripts and Protein Isoforms of Zebrafish R2 Gene

  2011cites this paper
• Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage Molecular Fast

  2011cites this paper
• Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage

  2011cites this paper
• p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest

  2011cites this paper
• Deoxynucleoside Salvage Facilitates DNA Repair During Ribonucleotide Reductase Blockade in Human Cervical Cancers

  2011cites this paper
• Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer.

  2011cites this paper
• Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage

  2011cites this paper
• Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers

  2010cites this paper
• Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.

  2010cites this paper
• Studies on Ribonucleotide Reductase, a Target for Anticancer Therapy, with Focus on Electron Donor Aspects -Thioredoxin and Glutaredoxin Systems

  2009cites this paper
• Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response*

  2009cites this paper
• Modulating Radiation Resistance by Inhibiting Ribonucleotide Reductase in Cancers with Virally or Mutationally Silenced p53 Protein

  2009cites this paper
• Regulation of p53R2 and its role as potential target for cancer therapy.

  2009cites this paper
• Mouse RS21‐C6 is a mammalian 2′‐deoxycytidine 5′‐triphosphate pyrophosphohydrolase that prefers 5‐iodocytosine

  2009cites this paper
• Genetic causes of mitochondrial DNA depletion in humans.

  2009cites this paper
• Integrated Bioinformatics for Radiation-Induced Pathway Analysis from Proteomics and Microarray Data.

  2008cites this paper
• Genotypes That Predict Toxicity and Genotypes That Predict Efficacy of Anticancer Drugs

  2008cites this paper
• Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.

  2008cites this paper
• Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case–control disease association study

  2008cites this paper
• ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage

  2008cites this paper
• An Association Between RRM 1 Haplotype and Gemcitabine-Induced Neutropenia in Breast Cancer Patients

  2007cites this paper
• Aloe-emodin induces in vitro G2/M arrest and alkaline phosphatase activation in human oral cancer KB cells.

  2007cites this paper
• Single cell expression profiling reveals major disruption of DNA repair capacity in incipient Alzheimer's Disease

  2007cites this paper
• Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.

  2007cites this paper
• Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion

  2007cites this paper
• An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.

  2007cites this paper
• Quantitative Phosphoproteome Profiling of Wnt3a-mediated Signaling Network

  2007cites this paper
• Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivo

  2007cites this paper
• Production of a Monoclonal Antibody Against the hRRM2 Subunit of Ribonucleotide Reductase and Immunohistochemistry Study of Human Cancer Tissues

  2006cites this paper
• Metastasis-Suppressing Potential of Ribonucleotide Reductase Small Subunit p53R2 in Human Cancer Cells

  2006cites this paper
• Ribonucleotide reductases.

  2006cites this paper
• Structurally dependent redox property of ribonucleotide reductase subunit p53R2.

  2006cites this paper
• Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

  2006cites this paper
• Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase.

  2006cites this paper
• DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer

  2006cites this paper
• Ribonucleotide reductase inhibitors and future drug design.

  2006cites this paper
• A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase

  2006cites this paper
• Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits.

  2006cites this paper
• Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy

  2005cites this paper
• Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells.

  2005cites this paper
• Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay.

  2005cites this paper
• The ribonucleotide reductase subunit M2B subcellular localization and functional importance for DNA replication in physiological growth of KB cells.

  2005cites this paper
• In Vitro Characterization of Enzymatic Properties and Inhibition of the p53R2 Subunit of Human Ribonucleotide Reductase

  2004cites this paper
• Stable Suppression of the R2 Subunit of Ribonucleotide Reductase by R2-targeted Short Interference RNA Sensitizes p53(–/–) HCT-116 Colon Cancer Cells to DNA-damaging Agents and Ribonucleotide Reductase Inhibitors*

  2004cites this paper
• Advances in Brief In Vitro Characterization of Enzymatic Properties and Inhibition of the p 53 R 2 Subunit of Human Ribonucleotide Reductase

  2004cites this paper
• Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.

  2003cites this paper
• WashU Scholarly

  year unknowncites this paper